HIV Epidemiology: Causes, Symptoms, and Global Impact
This paper provides a comprehensive overview of HIV epidemiology, examining the virus's biological mechanisms, modes of transmission, and clinical progression to AIDS. It outlines early symptoms, diagnostic procedures such as the ELISA and Western blot tests, and antiretroviral therapy as the primary treatment approach. The paper also addresses global and regional morbidity and prevalence data, with particular attention to Sub-Saharan Africa, and explores social determinants of health—including poverty, stigma, and lack of education—that influence infection rates. Finally, it discusses the role of community health nurses in case finding and follow-up, and describes how the CDC's National HIV Surveillance program works to reduce new infections in the United States.
- Introduction to HIV: Defines HIV, immune system impact, and AIDS
- Causes, Transmission, and Symptoms: Modes of transmission and early clinical symptoms
- Diagnosis and Treatment: ELISA, Western blot testing, and antiretroviral therapy
- Complications of Untreated HIV: Opportunistic infections when HIV progresses to AIDS
- Demographics: Morbidity, Incidence, Mortality, and Prevalence: Global and regional HIV prevalence statistics
- Social Determinants of Health and HIV: Poverty, stigma, and structural factors driving infection
- Community Health Nursing and National Agency Responses: Nurse roles and CDC surveillance programs
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Moves logically from biology to clinical presentation to public health response, giving the reader a complete picture of HIV as both a medical and a social phenomenon.
- Incorporates specific epidemiological data (e.g., 36.7 million people living with HIV by end of 2015, 4.4% prevalence in Sub-Saharan Africa) to ground abstract claims in measurable evidence.
- Connects individual-level determinants (poverty, stigma, lack of education) to structural and policy-level factors, demonstrating multi-level thinking about disease prevention.
Key academic technique demonstrated
The paper uses a classic epidemiological framework—agent, host, and environment—as an organizing principle, then extends it into a public health nursing context by discussing case finding, follow-up, and referral. This layered approach shows how clinical and community-level perspectives complement each other when addressing an infectious disease pandemic.
Structure breakdown
The paper opens with a biological definition of HIV before progressing through transmission, symptoms, diagnosis, and treatment. It then shifts to population-level analysis with demographic and prevalence statistics, examines social determinants, and closes with applied public health responses from community nurses and the CDC. Each section builds on the previous one, moving from micro to macro.
Introduction to HIV
HIV is a condition in which a virus attacks the immune system of the infected person. When the immune system is weakened, the body cannot effectively fight off diseases. The combination of the infection and the virus that triggers it is collectively referred to as HIV. The immune system relies heavily on white blood cells to carry out its defense functions. The HIV virus targets and destroys a specific type of white blood cell known as CD4 cells. When a significant number of these cells are destroyed, the body begins to lose its ability to fight infections.
The final stage of HIV infection is called AIDS—an abbreviation for acquired immunodeficiency syndrome. People with AIDS suffer from ailments not commonly experienced by healthy individuals. They may develop rare cancers and other infections that are often life-threatening.
Causes, Transmission, and Symptoms
The human immunodeficiency virus is the cause of HIV. Infection occurs through three main modes: parenteral transmission, sexual transmission, and mother-to-child transmission. The global pandemic has been driven primarily by HIV-1. HIV-2 is less communicable and is more commonly found in West Africa. There is little evidence to suggest that varying HIV-1 subtypes carry meaningfully different rates of transmission (Morison, 2001).
HIV symptoms typically do not appear immediately after infection; they usually emerge after a significant period of time and are often confused with influenza. Early common symptoms include:
- Fever
- Sore throat
- Headaches
- Joint pain or muscle aches
- Inflammation of lymph nodes
- Skin rashes
These symptoms may appear anywhere from a few days to several weeks after initial infection and typically resolve after a couple of weeks.
Diagnosis and Treatment
If a saliva or urine test indicates a positive result, a follow-up blood test is administered to confirm the findings. Most physicians use a dual blood test procedure that includes the ELISA and the Western blot. The second test is typically performed to eliminate any remaining doubt. Antibodies for HIV generally appear in the bloodstream within three months of infection, though they can take up to six months to become detectable.
A combination of medicines is used to treat HIV in modern medical practice. This combination is known as antiretroviral therapy, commonly abbreviated as ART. These medicines are effective in slowing the rate at which the HIV virus replicates and spreads. Using ART can help people remain healthy and live considerably longer than they would without treatment. Experts emphasize that beginning ART as soon as one is diagnosed with HIV infection is strongly advisable.
Complications of Untreated HIV
HIV weakens the body's immune system, making an infected individual significantly more likely to contract opportunistic infections or develop certain cancers. If a person infected with HIV does not seek treatment, the infection will progress to AIDS. Once AIDS develops, it cannot be cured, and the condition is typically fatal (rayur, 2012).
People with AIDS are vulnerable to any or all of the following opportunistic infections:
- Toxoplasmosis
- Tuberculosis (TB)
- Candidiasis
- Cytomegalovirus
- Cryptococcal meningitis
- Cryptosporidiosis
Demographics: Morbidity, Incidence, Mortality, and Prevalence
To date, over 70 million individuals have been infected with HIV, and approximately 35 million of them have died. By the end of 2015, about 36.7 million people were reported to be living with HIV. Approximately 0.8% of people between the ages of 15 and 49 are living with the condition globally. It is important to note that the burden of the HIV pandemic varies significantly between countries.
Sub-Saharan Africa remains the most heavily affected region in the world. Data indicate at least one infection in every 25 people in the region, translating to approximately 4.4% of the total population. Worldwide, Sub-Saharan Africa accounts for over 70% of all HIV infections and people living with HIV (WHO, 2016). In the United States, approximately 40,000 new infections occur each year.
References
CATIE. (2016). The social determinants of health and structural interventions. Canada's source for HIV and hepatitis C information.
Hariri, S., & McKenna, M. T. (2007). Epidemiology of human immunodeficiency virus in the United States. Clinical Microbiology Reviews, 20(3), 478–488.
MDH. (2001, March). Public health interventions: Applications for public health nursing practice. Minnesota Department of Health, Division of Community Health Services, Public Health Nursing Section.
Morison, L. (2001). The global epidemiology of HIV/AIDS. British Medical Bulletin, 58(1), 7–18.
rayur. (2012, July 28). AIDS, HIV: Definition, causes, symptoms, diagnosis, complication, preventive, and treatment. http://www.rayur.com/aids-hiv-definition-causes-symptoms-diagnosis-complication-preventive-and-treatment.html
WHO. (2016). Global Health Observatory (GHO) data. World Health Organization. http://www.who.int/gho/hiv/en/
Create your account
Always verify citation format against your institution’s current style guide requirements.